PAREXEL International has expanded its services and capabilities for genomic-based drug development. The PAREXEL Genomic Medicine team now offers a variety of strategic and operational genomic research services aimed at accelerating drug development and to support regulatory and payer approval processes.   Increasingly, biopharma companies are applying genomics to drug discovery and development in an effort to better understand the genetic basis of disease, and regulators and payers are increa...